Bowen Chang

Dr. Bowen Chang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2014 in Journal of Plant Interactions
Verified
Journal Article
Open access
XGXiao-Rui Guo
Xiao-Rui Guo
BCBowen Chang
Bowen Chang
YZYuan-Gang Zu
Yuan-Gang Zu
Zhonghua TangZhonghua Tang
Zhonghua Tang
It has been reported that nitrate availability was able to modify the detrimental effects induced by excess ultraviolet-B (UV-B) radiation on plants. In this study, the medical plant Catharanthus roseus was subjected to UV-B stress and altered levels of nitrate nutrition to investigate their influence in a sole or combined way on growth and alkaloid productions. Our results showed that the UV-B stress obviously inhibited growth and led to damages of oxidative stress and lipid peroxidation. The simultaneous supply of higher nitrate nutrition could largely alleviate the inhibitory effects and damage symptom under the UV-B stress in C. roseus. Meanwhile, the UV-B-absorbing compounds as well as three alkaloids, vinblastine, vindoline, and catharanthine, were observed to have a remarkable elevation. These compounds were considered to serve as protectants of UV-B radiation. It was concluded that an increased nitrogen (N) supply could not only alleviate the inhibitory effect of UV-B stress on plant growth, but also enhance the accumulation of pharmaceutically used alkaloid in these plants. We proposed that the enrichment of N nutrition might provide more N source for alkaloid synthesis induced by UV-B radiation, eventually resulting in an increase of alkaloids accumulation.

1 August 2020 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
WZWanchun Zhu
Wanchun Zhu
JSJie Shen
Jie Shen
TTTianchi Tang
Tianchi Tang
BCBowen Chang
Bowen Chang
SLShiting Li
Shiting Li
MCMing Chen
Ming Chen

28 June 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
BCBowen Chang
Bowen Chang
CNChen Ni
Chen Ni
JMJiaming Mei
Jiaming Mei
CXChi Xiong
Chi Xiong
PCPeng Chen
Peng Chen
CNChaoshi Niu
Chaoshi Niu
Background: Parkinson’s disease is a common neurodegenerative disease, with depression being a common non-motor symptom. Bilateral subthalamic nucleus deep brain stimulation is an effective method for the treatment of Parkinson’s disease. Thus, this study aimed to establish a nomogram of the possibility of achieving a better depression improvement rate after subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease. Methods: We retrospectively analyzed 103 patients with Parkinson’s disease who underwent subthalamic nucleus deep brain stimulation and were followed up for the improvement of their Hamilton Depression scale scores 1 year postoperatively. Univariate and multivariate logistic regression analyses were used to select factors affecting the improvement rate of depression. A nomogram was then developed to predict the possibility of achieving better depression improvement. Furthermore, the discrimination and fitting performance was evaluated using a calibration diagram, receiver operating characteristics, and decision curve analysis. Results: The mean and median improvement rates of Hamilton Depression scores were 13.1 and 33.3%, respectively. Among the 103 patients, 70.8% had an improved depression, 23.3% had a worsened depression, and 5.8% remained unchanged. Logistic multivariate regression analysis showed that age, preoperative Parkinson’s Disease Questionnaire, Hamilton Anxiety, and Hamilton Depression scores were independent factors for the possibility of achieving a better depression improvement rate. Based on these results, a nomogram model was developed. The nomogram had a C-index of 0.78 (95% confidence interval: 0.69–0.87) and an area under the receiver operating characteristics of 0.78 (95% confidence interval: 0.69–0.87). The calibration plot and decision curve analysis further demonstrated goodness-of-fit between the nomogram predictions and actual observations. Conclusion: We developed a nomogram to predict the possibility of achieving good depression improvement 1 year after subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease, which showed a certain value in judging the expected depression improvement of these patients.

28 January 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
BCBowen Chang
Bowen Chang
JMJiaming Mei
Jiaming Mei
CNChen Ni
Chen Ni
CXChi Xiong
Chi Xiong
PCPeng Chen
Peng Chen
CNChaoshi Niu
Chaoshi Niu
Background: Parkinson’s disease (PD) represents one of the most frequently seen neurodegenerative disorders, while anxiety accounts for its non-motor symptom (NMS), and it has greatly affected the life quality of PD cases. Bilateral subthalamic nucleus deep brain stimulation (STN-DBS) can effectively treat PD. This study aimed to develop a clinical prediction model for the anxiety improvement rate achieved in PD patients receiving STN-DBS. Methods: The present work retrospectively enrolled 103 PD cases undergoing STN-DBS. Patients were followed up for 1 year after surgery to analyze the improvement in HAMA scores. Univariate and multivariate logistic regression were conducted to select factors affecting the Hamilton Anxiety Scale (HAMA) improvement. A nomogram was established to predict the likelihood of achieving anxiety improvement. Receiver operating characteristic (ROC) curve analysis, decision curve analysis (DCA), and calibration curve analysis were conducted to verify nomogram performance. Results: The mean improvement in HAMA score was 23.9% in 103 patients; among them, 68.9% had improved anxiety, 25.2% had worsened (Preop) anxiety, and 5.8% had no significant change in anxiety. Education years, UPDRS-III preoperative score, and HAMA preoperative score were independent risk factors for anxiety improvement. The nomogram-predicted values were consistent with real probabilities. Conclusions: Collectively, a nomogram is built in the present work for predicting anxiety improvement probability in PD patients 1 year after STN-DBS. The model is valuable for determining expected anxiety improvement in PD patients undergoing STN-DBS.

9 June 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
BCBowen Chang
Bowen Chang
CNChen Ni
Chen Ni
WZWeiwen Zhang
Weiwen Zhang
JMJiaming Mei
Jiaming Mei
CXChi Xiong
Chi Xiong
CNChaoshi Niu
Chaoshi Niu
Purpose: Parkinson’s disease (PD) is a common neurodegenerative disease, for which cognitive impairment is a non-motor symptom (NMS). Bilateral subthalamic nucleus deep brain stimulation (STN-DBS) is an effective treatment for PD. This study established a nomogram to predict cognitive improvement rate after STN-DBS in PD patients. Methods: We retrospectively analyzed 103 PD patients who underwent STN-DBS. Patients were followed up to measure improvement in MoCA scores one year after surgery. Univariate and multivariate logistic regression analyses were used to identify factors affecting improvement in cognitive status. A nomogram was developed to predict this factor. The discrimination and fitting performance were evaluated by receiver operating characteristics (ROC) analysis, calibration diagram, and decision curve analysis (DCA). Results: Among 103 patients, the mean improvement rate of the MoCA score was 37.3% and the median improvement rate was 27.3%, of which 64% improved cognition, 27% worsened cognition, and 8.7% remained unchanged. Logistic multivariate regression analysis showed that years of education, UPDRSIII drug use, MoCA Preop, and MMSE Preop scores were independent factors affecting the cognitive improvement rate. A nomogram model was subsequently developed. The C-index of the nomogram was 0.98 (95%CI, 0.97–1.00), and the area under the ROC was 0.98 (95%CI 0.97–1.00). The calibration plot and DCA demonstrated the goodness-of-fit between nomogram predictions and actual observations. Conclusion: Our nomogram could effectively predict the possibility of achieving good cognitive improvement one year after STN-DBS in patients with PD. This model has value in judging the expected cognitive improvement of patients with PD undergoing STN-DBS.

24 August 2020 in Journal of NeuroVirology
Verified
Journal Article
Closed access
PDF file
BCBowen Chang
Bowen Chang
XWXiangyu Wei
Xiangyu Wei
XWXueyi Wang
Xueyi Wang
YTYinda Tang
Yinda Tang
JZJin Zhu
Jin Zhu
SLShiting Li
Shiting Li